`_____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________________
`
`APOTEX INC., APOTEX CORP., ARGENTUM PHARMACEUTICALS LLC,
`ACTAVIS ELIZABETH LLC, TEVA PHARMACEUTICALS USA, INC., SUN
`PHARMACEUTICAL INDUSTIRES, LTD., SUN PHARMACEUTICAL
`INDUSTRIES, INC., AND SUN PHARMA GLOBAL FZE,
`Petitioners,
`
`v.
`
`NOVARTIS A.G.,
`Patent Owner.
`_____________________________
`
`IPR2017-00854
`Patent No. 9,187,405
`____________________________
`
`PETITIONERS TEVA AND ACTAVIS’S UPDATED MANDATORY
`NOTICES
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(3), Petitioners Actavis Elizabeth LLC and
`
`Teva Pharmaceuticals USA, Inc. (collectively, “Teva”) hereby submit the
`
`following Updated Mandatory Notices (“Notices”). Only those portions being
`
`updated are included herein.
`
`I.
`
`LEAD AND BACK-UP COUNSEL (37 C.F.R. § 42.8(B)(3))
`
`Lead Counsel
`Eugene Goryunov (Reg. No. 61,579)
`KIRKLAND & ELLIS LLP
`300 North LaSalle Street
`Chicago, Illinois 60654
`Telephone: (312) 862-2000
`Facsimile: (312) 862-2200
`eugene.goryunov@kirkland.com
`
`Back-Up Counsel
`Amanda Hollis (Reg. No. 55,629)
`KIRKLAND & ELLIS LLP
`300 North LaSalle
`Chicago, IL 60654
`Telephone: (312) 862-2000
`Facsimile: (312) 862-2200
`amanda.hollis@kirkland.com
`Gregory Springsted
`(admitted pro hac vice)
`KIRKLAND & ELLIS LLP
`601 Lexington Avenue
`New York, NY 10022
`Telephone: (212) 446-4800
`Facsimile: (212) 446-4900
`greg.springsted@kirkland.com
`
`A Power of Attorney pursuant to 37 C.F.R. § 42.10(b) has been filed in this
`
`matter.
`
`
`
`Date: May 7, 2018
`
`Respectfully submitted,
`
`/s/ Eugene Goryunov
`Eugene Goryunov (Reg. No. 61,579)
`KIRKLAND & ELLIS LLP
`300 North LaSalle Street
`Chicago, IL 60654
`P: (312) 862-2000
`F: (312) 862-2200
`eugene.goryunov@kirkland.com
`amanda.hollis@kirkland.com
`
`Attorneys For Teva
`
`2
`
`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. §§ 42.6(e) and 42.105(a), this is to certify that I
`
`caused to be served a true and correct copy of the foregoing Updated Mandatory
`
`Notices were served by overnight courier (Federal Express), on this 7th day of
`
`May, 2018, on the Patent Owner at the correspondence address of the Patent
`
`Owner as follows:
`
`Novartis Pharmaceutical Corporation
`Intellectual Property Department
`One Health Plaza 433/2
`East Hanover, NJ 07936-1080
`
`A courtesy copy of the foregoing was also served via email on the counsel of
`
`record for the Petitioner and Patent Owner in the Apotex IPR, IPR2017-00854, and
`
`the Argentum IPR, IPR2017-01550, the Sun IPR, IPR2017-01929 as follows:
`
`IPR2017-00854 Petitioner
`Steve Parmelee
`Michael Rosato
`Jad A. Mills
`Wilson Sonsini Goodrich & Rosati
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104
`sparmelee@wsgr.com
`mrosato@wsgr.com
`jmills@wsgr.com
`
`IPR2017-01550 Petitioner
`Terry Rea
`Deborah H. Yellin
`Shannon Lentz
`1001 Pennsylvania Avenue, NW
`Washington, DC 20004-2595
`
`Patent Owner
`Jane M. Love
`Robert W. Trenchard
`Gibson, Dunn & Crutcher LLP
`200 Park Avenue
`New York, NY 10166-0193
`jlove@gibsondunn.com
`rtrenchard@gibsondunn.com
`
`3
`
`
`
`trea@crowell.com
`dyellin@crowell.com
`slentz@crowell.com
`
`Tyler C. Liu
`Argentum Pharmaceuticals, LLC
`tliu@agpharm.com
`
`IPR2017-01929 Petitioner
`Samuel Park
`Charles B. Klein
`Winston & Strawn LLP
`35 W. Wacker Drive
`Chicago, IL 60601
`Telephone: (312) 558-7931
`SPark@winston.com
`CKlein@winston.com
`
`Date: May 7, 2018
`
`Respectfully submitted,
`
`/s/ Eugene Goryunov
`Eugene Goryunov (Reg. No. 61,579)
`KIRKLAND & ELLIS LLP
`300 North LaSalle Street
`Chicago, IL 60654
`P: (312) 862-2000
`F: (312) 862-2200
`eugene.goryunov@kirkland.com
`amanda.hollis@kirkland.com
`
`Attorneys For Teva
`
`4
`
`